Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories

Influenza is a viral infection that affects much of the global population each year. Vaccination remains the most effective tool for preventing the disease. Live attenuated influenza vaccine (LAIV) has been used since the 1950s to protect humans against seasonal influenza. LAIVs developed by the Ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudenko, Larisa, Yeolekar, Leena, Kiseleva, Irina, Isakova-Sivak, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357706/
https://www.ncbi.nlm.nih.gov/pubmed/27593158
http://dx.doi.org/10.1016/j.vaccine.2016.08.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357706/
https://www.ncbi.nlm.nih.gov/pubmed/27593158
http://dx.doi.org/10.1016/j.vaccine.2016.08.018

Ejemplares similares